Atul Auto Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 3, 2025, 8:13 pm

Quick Insight

Atul Auto Ltd, a player in the auto 2 & 3 wheeler industry, currently trades at ₹514 with a market capitalization of ₹1,427 Cr. The company's P/E ratio stands at 61.3, which appears elevated compared to the sector average of around 25–30x. Despite this, Atul Auto boasts a healthy Return on Equity (ROE) of 4.99% and Return on Capital Employed (ROCE) of 6.48%. The firm's Operating Profit Margin (OPM) of 6.55% is in line with industry standards, indicating efficient cost management. Additionally, with reserves at ₹427 Cr and a Price to Book Value (P/BV) ratio of 3.15x, Atul Auto demonstrates a strong financial position relative to its peers.

However, the company faces risks such as a relatively low ROE and ROCE, suggesting potential inefficiencies in capital utilization. Furthermore, the high P/E ratio could indicate overvaluation, leading to a possible correction in the stock price. With borrowings at ₹110 Cr, Atul Auto needs to carefully manage its debt levels, especially considering the Current Ratio and Interest Coverage Ratio stand at 3.17x, indicating a moderate ability to cover short-term obligations. Looking ahead, a key factor that could improve the company's outlook is a focus on enhancing operational efficiency and profitability, potentially leading to a re-rating of the stock. On the flip side, increasing competition or a slowdown in the auto sector could pose challenges for Atul Auto's growth trajectory. In conclusion, while Atul Auto exhibits financial stability, investors should closely monitor its operational performance and industry dynamics to make informed investment decisions.

Competitors of Atul Auto Ltd

All Competitor Stocks of Atul Auto Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:25 pm

Below is a detailed analysis of the quarterly data for Atul Auto Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 152.78 Cr.. The value appears to be declining and may need further review. It has decreased from 211.14 Cr. (Mar 2025) to 152.78 Cr., marking a decrease of 58.36 Cr..
• For Expenses, as of Jun 2025, the value is 142.77 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 196.03 Cr. (Mar 2025) to 142.77 Cr., marking a decrease of 53.26 Cr..
• For Operating Profit, as of Jun 2025, the value is 10.01 Cr.. The value appears to be declining and may need further review. It has decreased from 15.11 Cr. (Mar 2025) to 10.01 Cr., marking a decrease of 5.10 Cr..
• For OPM %, as of Jun 2025, the value is 6.55%. The value appears to be declining and may need further review. It has decreased from 7.16% (Mar 2025) to 6.55%, marking a decrease of 0.61%.
• For Other Income, as of Jun 2025, the value is 0.28 Cr.. The value appears to be declining and may need further review. It has decreased from 0.64 Cr. (Mar 2025) to 0.28 Cr., marking a decrease of 0.36 Cr..
• For Interest, as of Jun 2025, the value is 2.49 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.54 Cr. (Mar 2025) to 2.49 Cr., marking a decrease of 0.05 Cr..
• For Depreciation, as of Jun 2025, the value is 4.55 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.46 Cr. (Mar 2025) to 4.55 Cr., marking an increase of 0.09 Cr..
• For Profit before tax, as of Jun 2025, the value is 3.25 Cr.. The value appears to be declining and may need further review. It has decreased from 8.75 Cr. (Mar 2025) to 3.25 Cr., marking a decrease of 5.50 Cr..
• For Tax %, as of Jun 2025, the value is 36.62%. The value appears to be increasing, which may not be favorable. It has increased from 32.69% (Mar 2025) to 36.62%, marking an increase of 3.93%.
• For Net Profit, as of Jun 2025, the value is 2.06 Cr.. The value appears to be declining and may need further review. It has decreased from 5.89 Cr. (Mar 2025) to 2.06 Cr., marking a decrease of 3.83 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.06. The value appears to be declining and may need further review. It has decreased from 2.58 (Mar 2025) to 1.06, marking a decrease of 1.52.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 5:25 pm

Growth

Last Updated: September 5, 2025, 12:00 am

Balance Sheet

Last Updated: July 25, 2025, 3:33 pm

Below is a detailed analysis of the balance sheet data for Atul Auto Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
• For Reserves, as of Mar 2025, the value is 427.00 Cr.. The value appears strong and on an upward trend. It has increased from 406.00 Cr. (Mar 2024) to 427.00 Cr., marking an increase of 21.00 Cr..
• For Borrowings, as of Mar 2025, the value is 110.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 144.00 Cr. (Mar 2024) to 110.00 Cr., marking a decrease of 34.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 130.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 91.00 Cr. (Mar 2024) to 130.00 Cr., marking an increase of 39.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 680.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 655.00 Cr. (Mar 2024) to 680.00 Cr., marking an increase of 25.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 246.00 Cr.. The value appears to be declining and may need further review. It has decreased from 250.00 Cr. (Mar 2024) to 246.00 Cr., marking a decrease of 4.00 Cr..
• For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 23.00 Cr..
• For Other Assets, as of Mar 2025, the value is 433.00 Cr.. The value appears strong and on an upward trend. It has increased from 382.00 Cr. (Mar 2024) to 433.00 Cr., marking an increase of 51.00 Cr..
• For Total Assets, as of Mar 2025, the value is 680.00 Cr.. The value appears strong and on an upward trend. It has increased from 655.00 Cr. (Mar 2024) to 680.00 Cr., marking an increase of 25.00 Cr..

Notably, the Reserves (427.00 Cr.) exceed the Borrowings (110.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Atul Auto Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 3.39. This value is below the healthy minimum of 5. It has increased from 1.82 (Mar 23) to 3.39, marking an increase of 1.57.
• For Diluted EPS (Rs.), as of Mar 24, the value is 3.39. This value is below the healthy minimum of 5. It has increased from 1.82 (Mar 23) to 3.39, marking an increase of 1.57.
• For Cash EPS (Rs.), as of Mar 24, the value is 9.06. This value is within the healthy range. It has increased from 7.80 (Mar 23) to 9.06, marking an increase of 1.26.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 154.44. It has increased from 147.48 (Mar 23) to 154.44, marking an increase of 6.96.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 154.44. It has increased from 147.48 (Mar 23) to 154.44, marking an increase of 6.96.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 189.95. It has decreased from 214.87 (Mar 23) to 189.95, marking a decrease of 24.92.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 15.14. This value is within the healthy range. It has decreased from 15.81 (Mar 23) to 15.14, marking a decrease of 0.67.
• For PBIT / Share (Rs.), as of Mar 24, the value is 8.63. This value is within the healthy range. It has decreased from 9.32 (Mar 23) to 8.63, marking a decrease of 0.69.
• For PBT / Share (Rs.), as of Mar 24, the value is 3.86. This value is within the healthy range. It has increased from 2.42 (Mar 23) to 3.86, marking an increase of 1.44.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 2.55. This value is within the healthy range. It has increased from 1.31 (Mar 23) to 2.55, marking an increase of 1.24.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 3.23. This value is within the healthy range. It has increased from 1.68 (Mar 23) to 3.23, marking an increase of 1.55.
• For PBDIT Margin (%), as of Mar 24, the value is 7.97. This value is below the healthy minimum of 10. It has increased from 7.35 (Mar 23) to 7.97, marking an increase of 0.62.
• For PBIT Margin (%), as of Mar 24, the value is 4.54. This value is below the healthy minimum of 10. It has increased from 4.33 (Mar 23) to 4.54, marking an increase of 0.21.
• For PBT Margin (%), as of Mar 24, the value is 2.03. This value is below the healthy minimum of 10. It has increased from 1.12 (Mar 23) to 2.03, marking an increase of 0.91.
• For Net Profit Margin (%), as of Mar 24, the value is 1.34. This value is below the healthy minimum of 5. It has increased from 0.60 (Mar 23) to 1.34, marking an increase of 0.74.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 1.70. This value is below the healthy minimum of 8. It has increased from 0.77 (Mar 23) to 1.70, marking an increase of 0.93.
• For Return on Networth / Equity (%), as of Mar 24, the value is 2.13. This value is below the healthy minimum of 15. It has increased from 1.14 (Mar 23) to 2.13, marking an increase of 0.99.
• For Return on Capital Employeed (%), as of Mar 24, the value is 4.80. This value is below the healthy minimum of 10. It has decreased from 5.13 (Mar 23) to 4.80, marking a decrease of 0.33.
• For Return On Assets (%), as of Mar 24, the value is 1.37. This value is below the healthy minimum of 5. It has increased from 0.65 (Mar 23) to 1.37, marking an increase of 0.72.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.13. This value is below the healthy minimum of 0.2. It has decreased from 0.20 (Mar 23) to 0.13, marking a decrease of 0.07.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.34. This value is within the healthy range. It has decreased from 0.48 (Mar 23) to 0.34, marking a decrease of 0.14.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.83. It has decreased from 0.88 (Mar 23) to 0.83, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 24, the value is 1.67. This value is within the healthy range. It has increased from 1.21 (Mar 23) to 1.67, marking an increase of 0.46.
• For Quick Ratio (X), as of Mar 24, the value is 1.19. This value is within the healthy range. It has increased from 0.82 (Mar 23) to 1.19, marking an increase of 0.37.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 5.38. This value is within the healthy range. It has decreased from 6.18 (Mar 23) to 5.38, marking a decrease of 0.80.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 3.17. This value is within the healthy range. It has increased from 2.29 (Mar 23) to 3.17, marking an increase of 0.88.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.53. This value is below the healthy minimum of 3. It has increased from 1.19 (Mar 23) to 1.53, marking an increase of 0.34.
• For Enterprise Value (Cr.), as of Mar 24, the value is 1,453.08. It has increased from 915.35 (Mar 23) to 1,453.08, marking an increase of 537.73.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.76. This value is within the healthy range. It has increased from 1.78 (Mar 23) to 2.76, marking an increase of 0.98.
• For EV / EBITDA (X), as of Mar 24, the value is 34.57. This value exceeds the healthy maximum of 15. It has increased from 24.24 (Mar 23) to 34.57, marking an increase of 10.33.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.51. This value is within the healthy range. It has increased from 1.45 (Mar 23) to 2.51, marking an increase of 1.06.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Price / BV (X), as of Mar 24, the value is 3.15. This value exceeds the healthy maximum of 3. It has increased from 2.14 (Mar 23) to 3.15, marking an increase of 1.01.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.51. This value is within the healthy range. It has increased from 1.45 (Mar 23) to 2.51, marking an increase of 1.06.
• For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness